Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.2.23 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Allison K Krebs and 4 co-authors. Institution: Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States. Major MEDLINE topics: Oxidative Stress, Naltrexone, Dry Eye Syndromes, Lacrimal Apparatus. 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To determine whether topical naltrexone (NTX) treatment can decrease the elevated reactive oxygen species pathways and select proinflammatory cytokines in the rat cornea and lacrimal glands that are elevated in diabetic dry eye.
Methods
Type 1 diabetic male and female Sprague-Dawley rats were rendered hyperglycemic for 6-8 weeks and then treated topically with NTX eyedrops twice daily for 15 days. Corneal epithelium and lacrimal glands were evaluated for expression of dihydroethidium, C/EBP homologous protein, and NADPH oxidase -2 (NOX-2) as well as the proinflammatory cytokines interleukin (IL) -1β, IL-6, and tumor necrosis factor alpha (TNF-α) to identify pathways targeted in the mitigation of diabetic dry eye.
Results
Type 1 diabetes resulted in dry eye and corneal surface insensitivity, accompanied by increased levels of oxidative stress and inflammation mediators in both corneal epithelium and lacrimal glands. Topical NTX treatment restored tear volume and corneal surface sensitivity, and significantly reduced expression of dihydroethidium, C/EBP homologous protein, and NOX-2, as well as proinflammatory cytokines IL-1β, IL-6, and TNF-α in male and female diabetic rats.
Conclusions
Blockade of the opioid growth factor (OGF)-OGF receptor system with topical NTX rapidly reversed diabetic dry eye and restored corneal surface sensitivity. The mechanism involved downregulating oxidative stress and decreasing proinflammatory cytokines to levels at or below those of nondiabetic rats of the same sex. These findings support a mechanistic role for OGF receptor blockade in the reversal of diabetic dry eye.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Neuroscience and Experimental Therapeutics, Penn State University College of Medicine, Hershey, Pennsylvania, United States.
- Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States.
- Department of Ophthalmology and Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania, United States.
Cite
APA
Krebs, A. K., Diaz, D., Sassani, J. W., Zagon, I. S., & McLaughlin, P. J. (2026). Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.2.23
Vancouver
Krebs AK, Diaz D, Sassani JW, Zagon IS, McLaughlin PJ. Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.2.23
BibTeX
@article{Krebs2026,
author = {Krebs, Allison K and Diaz, David and Sassani, Joseph W and Zagon, Ian S and McLaughlin, Patricia J},
title = {Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.2.23}
}
EUVIMED